vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $58.8M, roughly 1.1× CBAK Energy Technology, Inc.). CBAK Energy Technology, Inc. runs the higher net margin — -12.5% vs -70.9%, a 58.4% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 8.1%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -0.0%).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CBAT vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $62.1M |
| Net Profit | $-7.4M | $-44.1M |
| Gross Margin | 7.3% | 52.9% |
| Operating Margin | -13.6% | -9.0% |
| Net Margin | -12.5% | -70.9% |
| Revenue YoY | 131.8% | 8.1% |
| Net Profit YoY | -63.6% | -557.1% |
| EPS (diluted) | $-0.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $62.1M | ||
| Q3 25 | $60.9M | $52.3M | ||
| Q2 25 | $40.5M | $45.6M | ||
| Q1 25 | $34.9M | $41.5M | ||
| Q4 24 | $25.4M | $57.5M | ||
| Q3 24 | $44.6M | $51.5M | ||
| Q2 24 | $47.8M | $46.6M | ||
| Q1 24 | $58.8M | $44.9M |
| Q4 25 | $-7.4M | $-44.1M | ||
| Q3 25 | $2.7M | $-5.5M | ||
| Q2 25 | $-3.1M | $-5.6M | ||
| Q1 25 | $-1.6M | $-11.4M | ||
| Q4 24 | $-4.5M | $9.6M | ||
| Q3 24 | $17.6K | $941.0K | ||
| Q2 24 | $6.4M | $-10.4M | ||
| Q1 24 | $9.8M | $-6.2M |
| Q4 25 | 7.3% | 52.9% | ||
| Q3 25 | 8.0% | 52.7% | ||
| Q2 25 | 11.0% | 52.3% | ||
| Q1 25 | 13.7% | 48.6% | ||
| Q4 24 | 13.1% | 58.5% | ||
| Q3 24 | 15.6% | 56.3% | ||
| Q2 24 | 26.6% | 54.6% | ||
| Q1 24 | 31.9% | 51.3% |
| Q4 25 | -13.6% | -9.0% | ||
| Q3 25 | -6.6% | -17.6% | ||
| Q2 25 | -8.7% | -23.3% | ||
| Q1 25 | -8.2% | -36.1% | ||
| Q4 24 | -26.0% | 5.2% | ||
| Q3 24 | -1.9% | -8.2% | ||
| Q2 24 | 12.4% | -18.3% | ||
| Q1 24 | 17.4% | -23.9% |
| Q4 25 | -12.5% | -70.9% | ||
| Q3 25 | 4.4% | -10.5% | ||
| Q2 25 | -7.6% | -12.2% | ||
| Q1 25 | -4.5% | -27.5% | ||
| Q4 24 | -17.8% | 16.8% | ||
| Q3 24 | 0.0% | 1.8% | ||
| Q2 24 | 13.5% | -22.4% | ||
| Q1 24 | 16.7% | -13.8% |
| Q4 25 | $-0.08 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $-0.02 | — | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $0.00 | — | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $0.11 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $90.9M |
| Total DebtLower is stronger | $4.1M | — |
| Stockholders' EquityBook value | $112.7M | $341.7M |
| Total Assets | $426.2M | $461.5M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $90.9M | ||
| Q3 25 | $10.5M | $93.3M | ||
| Q2 25 | $45.7M | $75.5M | ||
| Q1 25 | $9.6M | $95.3M | ||
| Q4 24 | $11.0M | $98.7M | ||
| Q3 24 | $24.2M | $162.3M | ||
| Q2 24 | $44.1M | $177.9M | ||
| Q1 24 | $23.8M | $168.8M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $4.9M | — | ||
| Q1 25 | $4.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $112.7M | $341.7M | ||
| Q3 25 | $121.4M | $378.6M | ||
| Q2 25 | $118.2M | $377.6M | ||
| Q1 25 | $120.8M | $379.6M | ||
| Q4 24 | $121.7M | $395.7M | ||
| Q3 24 | $131.2M | $385.5M | ||
| Q2 24 | $126.6M | $389.1M | ||
| Q1 24 | $120.9M | $392.6M |
| Q4 25 | $426.2M | $461.5M | ||
| Q3 25 | $363.9M | $494.9M | ||
| Q2 25 | $333.1M | $493.3M | ||
| Q1 25 | $311.5M | $482.6M | ||
| Q4 24 | $302.2M | $499.5M | ||
| Q3 24 | $293.5M | $491.2M | ||
| Q2 24 | $279.6M | $483.7M | ||
| Q1 24 | $286.5M | $492.1M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $-771.0K |
| Free Cash FlowOCF − Capex | $16.1M | $-1.8M |
| FCF MarginFCF / Revenue | 27.3% | -2.9% |
| Capex IntensityCapex / Revenue | 23.4% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $-771.0K | ||
| Q3 25 | $14.6M | $-3.9M | ||
| Q2 25 | $13.8M | $108.0K | ||
| Q1 25 | $-9.6M | $-125.0K | ||
| Q4 24 | $9.6M | $2.0M | ||
| Q3 24 | $19.7M | $13.2M | ||
| Q2 24 | $2.9M | $6.2M | ||
| Q1 24 | $7.4M | $4.0M |
| Q4 25 | $16.1M | $-1.8M | ||
| Q3 25 | $6.0M | $-4.6M | ||
| Q2 25 | $4.1M | $-1.5M | ||
| Q1 25 | $-22.3M | $-974.0K | ||
| Q4 24 | $3.9M | $1.1M | ||
| Q3 24 | $16.5M | $12.2M | ||
| Q2 24 | $2.5M | $5.2M | ||
| Q1 24 | $-454.0K | $3.4M |
| Q4 25 | 27.3% | -2.9% | ||
| Q3 25 | 9.9% | -8.7% | ||
| Q2 25 | 10.2% | -3.2% | ||
| Q1 25 | -63.9% | -2.3% | ||
| Q4 24 | 15.5% | 1.9% | ||
| Q3 24 | 37.1% | 23.7% | ||
| Q2 24 | 5.2% | 11.0% | ||
| Q1 24 | -0.8% | 7.6% |
| Q4 25 | 23.4% | 1.6% | ||
| Q3 25 | 14.1% | 1.3% | ||
| Q2 25 | 23.8% | 3.5% | ||
| Q1 25 | 36.3% | 2.0% | ||
| Q4 24 | 22.5% | 1.6% | ||
| Q3 24 | 7.0% | 2.0% | ||
| Q2 24 | 0.9% | 2.3% | ||
| Q1 24 | 13.4% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | 5.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | 1115.72× | 14.05× | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
